- Correction
- Open access
- Published:
Correction: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGF R-2 signaling pathway in hepatocellular carcinoma
Journal of Experimental & Clinical Cancer Research volume 42, Article number: 257 (2023)
The Original Article was published on 09 November 2020
Correction: J Exp Clin Cancer Res 39, 235 (2020)
Following publication of the original article [1], incorrect Additional File 1 has been uploaded. The correct file replacement is now processed and uploaded.
The correction does not affect the overall result or conclusion of the article. The original article has been corrected.
References
Teng F, Zhang JX, Chang QM, et al. LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma. J Exp Clin Cancer Res. 2020;39:235. https://doi.org/10.1186/s13046-020-01739-z.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The online version of the original article can be found at https://doi.org/10.1186/s13046-020-01739-z.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Table S1
. Primers and oligonucleotides sequences used in this study.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Teng, F., Zhang, JX., Chang, QM. et al. Correction: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGF R-2 signaling pathway in hepatocellular carcinoma. J Exp Clin Cancer Res 42, 257 (2023). https://doi.org/10.1186/s13046-023-02824-9
Published:
DOI: https://doi.org/10.1186/s13046-023-02824-9